Transarterial Radioembolization with Yttrium-90 Glass Microspheres: Distribution of Residual Activity and Flow Dynamics during Administration

Journal of Vascular and Interventional Radiology - Tập 31 - Trang 1467-1474 - 2020
Robert Drescher1, Philipp Seifert1, Falk Gühne1, Christian Kühnel1, René Aschenbach2, Martin Freesmeyer1
1Clinic of Nuclear Medicine, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany
2Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany

Tài liệu tham khảo

Bester, 2014, Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature, J Med Imaging Radiat Oncol, 58, 341, 10.1111/1754-9485.12163 Najran, 2017, Update on treatment options for advanced bile duct tumours: radioembolisation for advanced cholangiocarcinoma, Curr Oncol Rep, 19, 50, 10.1007/s11912-017-0603-8 Salem, 2017, Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience, Hepatology, 68, 1429, 10.1002/hep.29691 Ahmadzadehfar, 2014, Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method, Nucl Med, 53, 95 Ahmadzadehfar, 2015, Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5% glucose during administration, EJNMMI Res, 5, 54, 10.1186/s13550-015-0133-z Piana, 2014, Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes, HPB (Oxford), 16, 336, 10.1111/hpb.12135 BTG International. TheraSphere Reference Manual Europe, version US-USTHSP-2013-0569(2)a(1). 2017. Drescher, 2019, Ex vivo evaluation of residual activity and infusion dynamics in a commercially available yttrium-90 resin microsphere administration system, J Vasc Interv Radiol, 30, 1504, 10.1016/j.jvir.2018.10.019 Chao, 2017, Effect of substituting 50% isovue for sterile water as the delivery medium for SIR-Spheres: improved dose delivery and decreased incidence of stasis, Clin Nucl Med, 42, 176, 10.1097/RLU.0000000000001532 International, 2019, TheraSphere yttrium-90 glass microspheres instructions for use, version 990252, SPE, Rev, 8 Nickles, 2004, Assaying and PET imaging of yttrium-90: 1>>34 ppm>0, IEEE Nucl Sci Symp Conf Rec, 6, 3412 Sirtex Medical Limited. SIR-Spheres Microspheres Training Manual, version TRN-RW-05. 2014. Quirem Medical. Instructions for use: Ho-166-PLLA Microspheres, version LS-1101-10. 2017.